Fatemeh

Dr Fatemeh Moheimani

Senior Lecturer

My profile

Biography

After completing a doctoral degree in pharmacy in Iran, I migrated to Australia to follow my passion for research. I completed a Masters of Medical Science by research, investigating the effect of a novel polyunsaturated fatty acid on the development of atherosclerosis in the University of Adelaide. Then, I was offered an APA scholarship from the University of Sydney to undertake a PhD to investigate the molecular mechanism linking diabetes with atherosclerosis. During my PhD, I also attracted a prestigious GSK postgraduate ward.

Joining RMIT’s Thrombosis and Vascular Diseases Laboratory as a postdoctoral researcher in 2010, I focused on the role of different regulatory mechanisms of platelets during thrombosis formation. I joined the University of Newcastle in 2013 as a postdoctoral. Within the first year, I established the Airway Cell Biology laboratory and Air Liquid Interface (ALI) cell culture in Priority Research Centre of Healthy Lungs in the University of Newcastle, and Viruses, Infections/Immunity, Vaccines and Asthma (VIVA) in the Hunter Medical Research Institute (HMRI). Thereafter, I have established collaborations nationally and internationally, published manuscripts, attracted research funding, presented in national and international conferences and supervised and mentored a number of undergraduate and postgraduate students and junior staff.

I move from Australia to the UK to join Teesside University as a Lecturer in Biomedical Science in Sep 2018 and promoted to a Senior Lecture in 2021. I contributed to Teaching, Research and Scholarly activities at Teesside University. I led Genomics and Bioinformatics module (postgraduate), Cell Biology module (undergraduate) and Clinical Pharmacology module(undergraduate), and contributed to teaching in  Advanced Biological Aspects of Diseases module (postgraduate), Molecular and Cellular Pathology module, Human Ageing and Diseases module, Anatomy and Physiology module, Biological Methods module, Science Communications and Bioethics module, Clinical Correlations of Food and Nutrition module (postgraduate), Science Research Project module and Biomedical Science Research Project module. I supervised 18 final year research project students and 5 MSc research project students to successful completion. I have been also supervising a PhD student. I joined Manchester Metropolitan University in Aug 2022 as a Senior Lecturer in Cellular Genetics.

Interests and expertise

I am an academic with a passion for biomedical science research with the focus on respiratory diseases, education and communication of science.

Get in touch

0161 247 1189
John Dalton Building

Projects

My research interests are to understand the molecular mechanisms underlying respiratory diseases with the goal to provide novel and more effective interventions. My research focuses on epigenetic regulatory mechanisms, e.g. microRNAs and their targets, as one of the underlying mechanisms contributing to the pathology of asthma. I perform my research on human airway epithelial cells, which are the first line of defence against noxious inhaled particles and pathogens (e.g. respiratory viruses). The general hypothesis is that the structure and function of the epithelium is abnormal in asthmatics. My objectives are to find a clinically targetable epigenetic factor in epithelial cells of asthmatics to restore the airway epithelium integrity, using state-of-art epigenetic and proteomic techniques combined with novel drug delivery systems.

PhD and Research Opportunities

My laboratory offers PhD projects to understand the underlying mechanisms responsible for pathology of respiratory diseases. In particular, to understand the abnormalities of human airway epithelium in asthma and stimuli (e.g. respiratory viruses) that exacerbate this condition.

Teaching

I am contributing to the Scientist Training Program (STP). STP is part of the Department of Health’s Modernising Science Careers (MSC), a UK-wide government initiative to address the training and education needs of the whole healthcare science workforce in the National Health Service (NHS). I am leading the Introduction to Genomic Counselling Unit (6H7V0012). I am also the academic supervisor of the trainees in Respiratory and Sleep Science in Research Methods (6ACP7114), Research Project 1 (6ACP7115) and Research Project 2 (6ACP7116). Further, I contribute to teaching Advanced Biological Aspects of Disease Unit (6H7Z1002), Recent Advances in Biomedical Research Unit (6ABM7135) and Disorder Case Study Unit (6ABM7110) at postgraduate level.

I am also contributing to Foundation Human Cell & Genetics (6H3Z3003), Research Skills and Employability (6H4Z1022), Genetic Science (6H6Z1038), Cell and Molecular Biology Unit (6H4Z1023) and Project (6H6Z1032) units at undergraduate level.

I am co-supervising one candidate for Doctoral Research and Innovation in Clinical Science Unit (6ACP8024) at MMU and supervising a PhD student at Teesside University. To date I have supervised 3 PhD students to successful completion.

Supervision

PhD and Research Opportunities

My laboratory offers PhD projects to understand the underlying mechanisms responsible for pathology of respiratory diseases. In particular, to understand the abnormalities of human airway epithelium in asthma and stimuli (e.g. respiratory viruses) that exacerbate this condition.

During the PhD projects the candidates will learn and use a wide range of novel techniques, including advanced cell culture, epigenetics, genetics, and protein detection techniques, in vitro.

Are you interested in developing new skills to progress your career? The Moheimani’s lab is always searching for talented and driven students to join the team.

  • Funded Positions: These will be advertised as they become available.
  • Self-Funded Positions: There is a variety of projects available for students wishing to self-fund their postgraduate studies (MRes or PhD). Please contact Fatemeh if you would like to discuss this further.

Research outputs

Original research papers:

  • Reid AT, Nichol KS, Chander-Veerati P, Moheimani F, Kicic A, Stick SM, Bartlett NW, Grainge CL, Wark PAB, Hansbro PM, Knight DA. Blocking Notch3 signalling abolishes MUC5AC production in airway epithelial cells from asthmatics. Am J Respir Cell Mol Biol. 2020 Apr;62(4):513-523. doi: 10.1165/rcmb.2019-0069OC. PMID: 31922915.
  • Moheimani F, Koops J, Williams T, Reid AT, Hansbro PM, Wark PA, Knight DA. Influenza A virus infection dysregulates the expression of microRNA‐22 and its targets; CD147 and HDAC4, in epithelium of asthmatics. Respir Res. 2018 Aug 2;19(1):145. doi: 10.1186/s12931-018-0851-7. PMID: 30068332.
  • Hsu AC, Parsons K, Moheimani F, Knight DA, Hansbro PM, Fujita T, Wark PA. Impaired Antiviral Stress Granule and IFN-β Enhanceosome Formation Enhances Susceptibility to Influenza Infection in COPD Epithelium. Am J Respir Cell Mol Biol. 2016 Jul;55(1):117-27. doi: 10.1165/rcmb.2015-0306OC. PMID: 26807508.
  • Sercombe L, Veerati T, Moheimani F, Wu SY, Sood A, Hua S. Advances and Challenges of Liposome Assisted Drug Delivery. Front Pharmacol. 2015 Dec 1;6:286. doi: 10.3389/fphar.2015.00286. Review. PMID: 26648870.
  • Moheimani F, Roth HM, Cross J, Reid AT, Shaheen F, Warner SM, Hirota JA, Kicic A, Hallstrand TS, Kahn M, Stick SM, Hansbro PM, Hackett TL, Knight DA. Disruption of β-Catenin/CBP signaling inhibits human airway epithelial-mesenchymal transition and repair. Int J Biochem Cell Biol. 2015 Nov;68:59-69. doi: 10.1016/j.biocel.2015.08.014. PMID: 26315281.
  • Makkawi M, Moheimani F, Alserihi R, Howells D, Wright M, Ashman L, and Jackson DE. A complementary role for tetraspanin superfamily member CD151 and ADP purinergic P2Y12 receptor in platelets. Thromb Haemost. 2015 Nov;114(5):1004-19. doi: 10.1160/TH14-11-0967. Epub 2015 Aug 6. PMID: 26245294.
  • Hirota JA, Marchant DJ, Singhera GK, Moheimani F, Dorscheid DR, Carlsten C, Sin DD, Knight DA. Urban particulate matter primes human airway epithelial cell IL-1β secretion to subsequent H1N1 influenza A exposure in vitro. Exp Lung Res. 2015;41(6):353-62. doi: 10.3109/01902148.2015.1040528. PMID: 26151556.
  • Alshahrani MM, Yang E, Yip J, Ghanem SS, Abdallah SL, deAngelis AM, O’Malley CJ, Moheimani F, Najjar SM, Jackson DE. CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo. Blood. 2014 Oct 9;124(15):2431-41. doi: 10.1182/blood-2014-04-569707. PMID: 25085348.
  • Moheimani F, Kim CH, Rahmanto AS, van Reyk DM, Davies MJ. Inhibition of lysosomal function in macrophages incubated with elevated glucose concentrations: a potential contributory factor in diabetes-associated atherosclerosis. Atherosclerosis. 2012 Jul;223(1):144-51. doi: 10.1016/j.atherosclerosis.2012.04.026.
  • Moheimani F, Tan JT, Brown BE, Heather AK, van Reyk DM, Davies MJ. Effect of exposure of human monocyte-derived macrophages to high, versus normal, glucose on subsequent lipid accumulation from glycated and acetylated low-density lipoproteins. Exp Diabetes Res. 2011;2011:851280. doi: 10.1155/2011/851280.
  • Moheimani F, Moore L, Ferrante JV, Trout N, Hii CS, Ferrante A. Inhibition of atherosclerotic lesion development in the apoE-/- mouse by a novel β-oxa polyunsaturated fatty acid. J Cardiovasc Pharmacol. 2010 Oct;56(4):431-9. doi: 10.1097/FJC.0b013e3181f1d420.
  • Moheimani F, Morgan PE, van Reyk DM, Davies MJ. Deleterious effects of reactive aldehydes and glycated proteins on macrophage proteasomal function: possible links between diabetes and atherosclerosis. Biochim Biophys Acta. 2010 Jun;1802(6):561-71. doi: 10.1016/j.bbadis.2010.02.007.
  •  Bahri Najafi R, Mohammadi Samani S, Pishva N, Moheimani F. Formulation and clinical Evaluation of Povidone-Iodine Ophthalmic Drops. Iranian Journal of Pharmaceutical Research. Aug 2003, 2: 157-160.

Review articles:

  • Reid AT, Veerati PC, Gosens R, Bartlett NW, Wark PA, Grainge CL, Stick SM, Kicic A, Moheimani F, Hansbro PM, Knight DA. Persistent induction of goblet cell differentiation in the airways: Therapeutic approaches. Pharmacol Ther. 2018 May;185:155-169. doi: 10.1016/j.pharmthera.2017.12.009. Epub 2017 Dec 27. Review. PMID: 29287707.
  • Moheimani F, Hsu ACY, Reid A, Williams T, Kicic A, Stick SM, Hansbro PM, Wark PA and Knight DA. The genetic and epigenetic landscapes of the epithelium in asthma Respir Res. 2016 Sep 22;17(1):119. doi: 10.1186/s12931-016-0434-4. PMID: 27658857.
  • Moheimani F, Jackson DE. P2Y12 receptor: platelet thrombus formation and medical interventions. International Journal of Hematology: Int J Hematol. 2012 Nov;96(5):572-87. doi: 10.1007/s12185-012-1188-5. Review.
  • Moheimani F, Jackson DE. Venous Thromboembolism: classification, risk factors, diagnosis and management. ISRN Hematol. 2011;2011:124610. doi: 10.5402/2011/124610.

Correspondence Letter

  • Moheimani F, Shahdab N, Cummings S, Hansbro F Moheimani, N Shahdab, S Cummings, PM Hansbro, Ward C. Key role of dysregulated airway epithelium in response to respiratory viral infections in asthma. ERJ Open Research 2022; DOI: 10.1183/23120541.00314-2022.

Publications for general audience

Conference organiser

  • Organising committee member:       The 13th Annual Newcastle Asthma Meeting (NAMe13), 26-27 Oct 2017, the Hunter Medical Research Institute, Newcastle, Australia
  • Organising committee member:       The 2nd Annual Airway epithelium workshop, 20-21 Nov 2014, the Hunter Medical Research Institute, Newcastle, Australia.

Chairing session

  • SIG Posters: Asthma and Allergy 2, 28 Mar 2017, TSANZRS Annual Scientific Meeting, 24-28 Mar 2017, National Convention Centre, Canberra, Australia.
  • 2.    Issues in respiratory disease phenotypes session:            The 11th Annual Newcastle Asthma Meeting (NAMe11), 22-23 Oct 2015, the Hunter Medical Research Institute, Newcastle, Australia.

Conference Presentation (oral or poster - from 2014)

  • Shahdab N, Ward C, Cummings S, Moheimani F. Conditions affecting bronchial epithelial cells responses to poly (I:C). Accepted for ERS international Congress, 4-6 Sep 2022, Barcelona (poster).
  • Shahdab N, Ward C, Cummings S, Moheimani F. Bronchial epithelial cell culture conditions affect their response to poly (I:C), TSANZRS Annual Scientific Meeting, 31 Mar-2 April 2022, Australia (virtual), (poster).
  • Moheimani F, Williams T, Reid AT, Hansbro PM, Wark PA, Knight DA. Abnormal miRNA-22 expression after influenza infection facilitates epithelium remodelling in asthma. TSANZRS Annual Scientific Meeting, 23-27 Mar 2018, Adelaide Convention and Exhibition Centre, Adelaide, Australia (Poster).
  • Moheimani F, Wark PA, Knight DA. Enhanced CD147 Expression After H1N1 Infection; A Potential Mechanism for Airway Epithelium Impairment in Asthma. 22nd Congress of the Asian Pacific Society of Respirology, Sydney, Australia. 23-26 November 2017 (oral).
  • Moheimani F, Williams T, Koops J, Reid AT, Hansbro PM, Wark PA, Knight DA. microRNAs as Potential Epigenetic Targets to Restore the Airway Epithelium Integrity in Asthmatics. American Thoracic Society (ATS) 2017 International Conference, May 19-24 2017, Walter E. Washington Convention Centre, Washington, DC, USA (Poster).
  • Reid AT, Moheimani F, Hansbro PM, Wark PA, Knight DA. Short-Term Inhibition of NOTCH Signalling Ablates MUC5AC Production in Human Airway Epithelial Cells from Asthmatic, Non-Asthmatic and COPD Donors. American Thoracic Society (ATS) 2017 International Conference, May 19-24 2017, Walter E. Washington Convention Centre, Washington, DC, USA (Poster).
  • Moheimani F, Koops J, Williams T, Reid AT, Wark PA, Knight DA. Potential protective role of microRNA-22 against airway remodelling. TSANZRS Annual Scientific Meeting, 24-28 Mar 2017, National Convention Centre, Canberra, Australia (Oral).
  • Veerati P, Bartlett N, Parsons K, Moheimani F, Wark P, Knight D, Grainge C. Mechanical Forces Attenuate Anti-viral Immunity in Primary Human Airway Epithelial Cells from Asthmatic Donors. TSANZRS Annual Scientific Meeting, 24-28 Mar 2017, National Convention Centre, Canberra, Australia (Oral).
  • Reid AT, Moheimani F, Nichol K, N Bartlett, Wark PA, Grainge C, Knight DA. Acute Inhibition of Notch Signalling Ablates Muc5ac Production in Human Airway Epithelial Cells from Asthmatic, Non-Asthmatic and COPD Donors. TSANZRS Annual Scientific Meeting, 24-28 Mar 2017, National Convention Centre, Canberra, Australia (Oral).
  • Moheimani F, Koops J, Williams T, Reid AT, Hansbro PM, Wark PA, Knight DA. Abnormal microRNAs expression in epithelial cells of severe asthmatics. 21st Congress of the Asian Pacific Society of Respirology (APSR 2016), Bangkok, Thailand. 12-15 November 2016 (oral).
  • Moheimani F, Koops J, Williams T, Reid AT, Wark PA, Knight DA. microRNA expression abnormalities in epithelial cells from asthmatics. TSANZSRS Annual Scientific Meeting, Perth, WA. 1– 6 April 2016 (oral).
  • Moheimani F, Starkey M, Reid A, Hunter T, Essilfie AT, Kahn M, Hansbro P, Knight D. Disruption of β-catenin signalling ameliorates mucus cell hyperplasia in a murine model of allergic airway inflammation. 2nd Australian Society for Medical Research (ASMR) Satellite Scientific Meeting. The University of Newcastle, Newcastle. 2 April 2015 (oral).
  • Moheimani F, Roth HM, Cross J, Reid AT, Shaheen F, Warner SM, Hackett TL, Hirota JA, Utokaparch S, Kicic A, Hansbro PM, Hallstrand TS, Kahn M, Stick SM, Knight DA. Suppression of β-Catenin/CBP signaling inhibits epithelial-mesenchymal transition and migration of human airway epithelium. TSANZSRS Annual Scientific Meeting, Gold Coast, QLD, 2015. 28 March – 1 April 2015 (poster).
  • Moheimani F. How can we translate ideas into productive outcomes by making most of state of art technologies? 2nd Annual Respiratory Epithelium Workshop. The Hunter Medical Research Institute, Newcastle. 24-25 November 2014 (oral).
  • Moheimani F, Roth HM, Cross J, Reid AT, Shaheen F, Warner SM, Hackett TL, Hirota JA, Utokaparch S, Kicic A, Hansbro PM, Hallstrand TS, Kahn M, Stick SM, Knight DA. Inhibition of β-Catenin/CBP signaling prevents epithelial-mesenchymal transition and migration of human airway epithelium.7th Australian Health & Medical Research Congress 2014. Melbourne, 16th - 19th November 2014 (poster).
  • Moheimani F. miR-132: A potential link between impaired innate immune response and dysregulated regeneration in epithelium of asthmatics. VIVA seminar series, HMRI, Newcastle. 23 July 2014 (oral).

Reviewership

Manuscripts

  • Clinical and Translational Medicine (2020)
  • Cell Transplantation (2019)
  • Biochemical Pharmacology (2018)
  • Stem cells (2018)
  • Epigenomics (2018)
  • Scientific Reports (2017)

Grants and Fellowships

  • Medical Research Council, UKRI MRC (2021)
  • A grant for Asthma UK and British Lung Foundation, UK (2021)
  • Australian Government National Health and Medical Research Council (NHMRC) external assessor (2018)
  • Grant focus group, HMRI, Newcastle (2018)
  • Eleven project grants, HMRI project grant assessment panel, Newcastle (2017)
  • A grant for the British Lung Foundation, UK (2017)
  • A grant for the executive government agency of National Science Centre, Poland (2017)
  • one postdoctoral MAX KADE fellowship for the Austrian Academy of Sciences (2014)

Societies and Professional Memberships:

  • 2021 – present: Academy of Higher Education
  • 2019 – present: European Respiratory Society
  • 2013 – present: Thoracic Society of Australia and New Zealand

  • Journal articles

    Moheimani, F., Shahdab, N., Cummings, S., Hansbro, P.M., Ward, C. (2022) 'Key role of dysregulated airway epithelium in response to respiratory viral infections in asthma.' ERJ Open Research, 8(3)

    Reid, A.T., Nichol, K.S., Veerati, P.C., Moheimani, F., Kicic, A., Stick, S.M., Bartlett, N.W., Grainge, C.L., Wark, P.A.B., Hansbro, P.M., Knight, D.A. (2020) 'Blocking notch3 signaling abolishes MUC5AC production in airway epithelial cells from individuals with asthma.' American Journal of Respiratory Cell and Molecular Biology, 62(4) pp. 513-523.

    Moheimani, F., Koops, J., Williams, T., Reid, A.T., Hansbro, P.M., Wark, P.A., Knight, D.A. (2018) 'Influenza A virus infection dysregulates the expression of microRNA-22 and its targets; CD147 and HDAC4, in epithelium of asthmatics.' Respiratory Research, 19(1)

    Reid, A.T., Veerati, P.C., Gosens, R., Bartlett, N.W., Wark, P.A., Grainge, C.L., Stick, S.M., Kicic, A., Moheimani, F., Hansbro, P.M., Knight, D.A. (2018) 'Persistent induction of goblet cell differentiation in the airways: Therapeutic approaches.' Pharmacology and Therapeutics, 185pp. 155-169.

    Moheimani, F., Hsu, A.C.Y., Reid, A.T., Williams, T., Kicic, A., Stick, S.M., Hansbro, P.M., Wark, P.A.B., Knight, D.A. (2016) 'The genetic and epigenetic landscapes of the epithelium in asthma.' Respiratory Research, 17(1)

    Hsu, A.C.Y., Parsons, K., Moheimani, F., Knight, D.A., Hansbro, P.M., Fujita, T., Wark, P.A. (2016) 'Impaired antiviral stress granule and IFN-β enhanceosome formation enhances susceptibility to influenza infection in chronic obstructive pulmonary disease epithelium.' American Journal of Respiratory Cell and Molecular Biology, 55(1) pp. 117-127.

    Moheimani, F., Roth, H.M., Cross, J., Reid, A.T., Shaheen, F., Warner, S.M., Hirota, J.A., Kicic, A., Hallstrand, T.S., Kahn, M., Stick, S.M., Hansbro, P.M., Hackett, T.L., Knight, D.A. (2015) 'Disruption of β-catenin/CBP signaling inhibits human airway epithelial-mesenchymal transition and repair.' International Journal of Biochemistry and Cell Biology, 68pp. 59-69.

    Hirota, J.A., Marchant, D.J., Singhera, G.K., Moheimani, F., Dorscheid, D.R., Carlsten, C., Sin, D., Knight, D. (2015) 'Urban particulate matter increases human airway epithelial cell IL-1β secretion following scratch wounding and H1N1 influenza A exposure in vitro.' Experimental Lung Research, 41(6) pp. 353-362.

    Sercombe, L., Veerati, T., Moheimani, F., Wu, S.Y., Sood, A.K., Hua, S. (2015) 'Advances and challenges of liposome assisted drug delivery.' Frontiers in Pharmacology, 6(DEC)

    Makkawi, M., Moheimani, F., Alserihi, R., Howells, D., Wright, M., Ashman, L., Jackson, D.E. (2015) 'A complementary role for tetraspanin superfamily member CD151 and ADP purinergic P2Y12 receptor in platelets.' Thrombosis and Haemostasis, 114(5) pp. 1004-1019.

    Alshahrani, M.M., Yang, E., Yip, J., Ghanem, S.S., Abdallah, S.L., De Angelis, A.M., O'Malley, C.J., Moheimani, F., Najjar, S.M., Jackson, D.E. (2014) 'CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo.' Blood, 124(15) pp. 2431-2441.

    Moheimani, F., Jackson, D.E. (2012) 'P2Y12 receptor: Platelet thrombus formation and medical interventions.' International Journal of Hematology, 96(5) pp. 572-587.

    Moheimani, F., Kim, C.H.J., Rahmanto, A.S., van Reyk, D.M., Davies, M.J. (2012) 'Inhibition of lysosomal function in macrophages incubated with elevated glucose concentrations: A potential contributory factor in diabetes-associated atherosclerosis.' Atherosclerosis, 223(1) pp. 144-151.

    Moheimani, F., Tan, J.T.M., Brown, B.E., Heather, A.K., Van Reyk, D.M., Davies, M.J. (2011) 'Effect of exposure of human monocyte-derived macrophages to high, versus normal, glucose on subsequent lipid accumulation from glycated and acetylated low-density lipoproteins.' Experimental Diabetes Research, 2011

    Moheimani, F., Jackson, D.E. (2011) 'Venous thromboembolism: classification, risk factors, diagnosis, and management..' ISRN hematology, 2011

    Moheimani, F., Morgan, P.E., van Reyk, D.M., Davies, M.J. (2010) 'Deleterious effects of reactive aldehydes and glycated proteins on macrophage proteasomal function: Possible links between diabetes and atherosclerosis.' Biochimica et Biophysica Acta - Molecular Basis of Disease, 1802(6) pp. 561-571.

    Moheimani, F., Moore, L., Ferrante, J.V., Trout, N., Hii, C.S., Ferrante, A. (2010) 'Inhibition of atherosclerotic lesion development in the ApoE-/- mouse by a novel β-oxa polyunsaturated fatty acid.' Journal of Cardiovascular Pharmacology, 56(4) pp. 431-439.

    Bahri Najafi, R., Mohammadi Samani, S., Pishva, N., Moheimani, F. (2003) 'Formulation and clinical Evaluation of Povidone-Iodine Ophthalmic Drops..' Iranian Journal of Pharmaceutical Research, (2) pp. 157-160.

  • Conference papers

    Shahdab, N., Ward, C., Cummings, S., Young, J.S., Moheimani, F. (2023) 'Response of bronchial and alveolar epithelial cells to poly (I:C).' In ERS International Congress 2023 abstracts. European Respiratory Society,

    Shahdab, N., Ward, C., Cummings, S., Moheimani, F. (2022) 'Conditions affecting bronchial epithelial cells responses to poly (I:C).' In ERS International Congress 2022 abstracts. European Respiratory Society,

  • Posters

    Shahdab, N., Ward, C., Cummings, S., Moheimani, F. (2022) 'Bronchial epithelial cell culture conditions affect their response to poly (I:C).' [Poster] In TSANZRS Annual Scientific Meeting. Date viewed 31/3/2022.